Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Beijing Tang Yi Hui Kang Biomedical Technology Co., LTD
The National Key Research and Development Program of China (2022YFC2105400)
- License Information
-
More Information
Article History
Received: 6 June 2023
Accepted: 25 September 2023
First Online: 4 October 2023
Declarations
:
: Human umbilical cord mesenchymal stem cells are provided by Beijing Tang Yi Hui Kang Biomedical Co., Ltd. The procedure for collecting tissues was approved by the Medical Ethics Committee of Jilin Guojian High-tech Maternity Hospital (Approval Number: 2021 Lunshen New Technology Character No. 10, September 16, 2021). Approved project: Neonatal umbilical cord tissue preservation project. Written informed consent has been obtained from the participate(s).
: Not applicable.
: Corresponding author Liming Ouyang has received research grants from Beijing Tang Yi Hui Kang Biomedical Technology Co., Ltd. Author Yulin Cao is a senior executive at Beijing Tang Yi Hui Kang Biomedical Technology Co., Ltd., that has invested in the research and holds shares in the company. The other authors declare no competing interests.
